AI Chatbots Fail to Reliably Identify Validated Home Blood Pressure Monitors, Study Finds
A new study presented at the American Heart Association's Hypertension Scientific Sessions 2026 reveals that popular AI search tools often misidentify validated home blood pressure monitors, potential...
Avident Health and Unite for HER Receive NCCN and Pfizer Grant to Improve Metastatic Breast Cancer Care
Avident Health and Unite for HER have been awarded a quality improvement grant from Pfizer and NCCN to deploy a digital navigation platform that enhances education, supportive care access, and caregiv...
Avatar Medical Secures CE Marking for Glasses-Free 3D Medical Imaging Software
Avatar Medical has obtained CE marking for its Avatar Medical Vision software, the first such approval for a platform compatible with glasses-free 3D medical displays, enabling commercialization in Eu...
Avatar Medical Vision Earns CE Mark for Glasses-Free 3D Surgical Planning
Avatar Medical has received CE Marking for Avatar Medical Vision, making it the first software approved for use with a glasses-free 3D medical display, which could streamline surgical planning and pat...
New Guidance Urges Breast Cancer Risk Assessment by Age 25, Not 40
The American College of Radiology now recommends that all women undergo a formal breast cancer risk assessment by age 25 to enable personalized screening and earlier detection, especially for high-ris...
Quantum BioPharma Partners with Thermo Fisher to Launch Phase 2 Lucid-MS Trial for Multiple Sclerosis
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher Scientific's clinical research business to initiate a Phase 2 trial of Lucid-MS, a novel neuroprotective treatment for multip...
VERAXA Biotech Advances FDA-Aligned Methods to Reduce Animal Testing in Cancer Research
VERAXA Biotech's new FDA-aligned approach could cut animal testing and speed up development of cancer therapies.
SS Innovations Advances Telerobotic Surgery with 195 Remote Procedures
SS Innovations International reports 195 telesurgeries and a 45% increase in its SSi Mantra installed base, highlighting the growing momentum of remote robotic surgery as the company pursues FDA clear...
Lantern Pharma Gains Taiwan Approvals for Phase 2 HARMONIC Trial of LP-300 in Lung Cancer
Lantern Pharma has received regulatory and IRB approvals in Taiwan to open Part 2 of its Phase 2 HARMONIC trial of LP-300, potentially accelerating development of a targeted therapy for EGFR L858R mut...
Quantum BioPharma Partners with Thermo Fisher to Launch Phase 2 Trial of Lucid-MS, a Novel Neuroprotective Approach to Multiple Sclerosis
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher Scientific's clinical research business to implement a Phase 2 trial of Lucid-MS, a drug candidate that targets demyelination...
XORTX Therapeutics Advances XORLO for Gout with FDA Submission on the Horizon
XORTX Therapeutics is developing XORLO, a new gout treatment that may offer better tolerability than existing therapies, as it prepares for an FDA new drug application submission.
National C60 Day Highlights Growing Interest in Fullerene Wellness Research
C60 Power marks National C60 Day on October 9 with a 20% sale and educational events, drawing attention to fullerenes' potential in health and longevity.
National C60 Day Highlights Nobel Prize-Winning Molecule and Its Potential in Healthy Aging Research
C60 Power celebrates National C60 Day on October 9 to honor the discovery of Carbon 60 and promote education on its potential health benefits, offering a 20% storewide sale and research resources.
Telomir Pharmaceuticals Raises $5.6M PIPE to Advance Telomir-Zn into Phase 1/2 TNBC Trial
Telomir Pharmaceuticals has secured approximately $5.6 million in PIPE financing to support clinical development of Telomir-Zn, its lead candidate for advanced or metastatic triple-negative breast can...
Quantum BioPharma Initiates Phase 2 Trial of Lucid-MS for Multiple Sclerosis with Thermo Fisher Support
Quantum BioPharma has signed a Study Start-Up Agreement with Thermo Fisher Scientific to launch a Phase 2 trial of Lucid-MS, a first-in-class neuroprotective candidate for progressive multiple scleros...
Skull's Hidden Lymphatic Structures May Revolutionize Brain Disease Treatment
A new study reveals lymph-node-like structures in the skull's bone marrow, suggesting the brain has a localized immune defense system that could lead to innovative treatments for brain cancers and oth...
Kairos Pharma's ENV-105 Shows Significant Progression-Free Survival Benefit in Phase 2 Prostate Cancer Trial
Kairos Pharma's ENV-105 combined with apalutamide significantly improved progression-free survival in metastatic castration-resistant prostate cancer, leading to a protocol amendment to enroll patient...
AXIM Biotechnologies Submits 510(k) to FDA for Rapid Point-of-Care Tear Lactoferrin Test for Dry Eye Disease
AXIM Biotechnologies has submitted a 510(k) to the FDA for a next-generation, rapid point-of-care test that measures tear lactoferrin to aid in diagnosing aqueous deficient dry eye disease, with plans...
BFCH and NEXT10 Outline Plan to Build Scalable Health, Wellness and Longevity Platform
BitFrontier Capital Holdings and NEXT10 have detailed a strategy to build UNLOCKD into a scalable health, wellness, and longevity platform, targeting 5-7 consumer brands, $65-$95 million in annual rev...
Market Street Capital Bridges Capital Markets Discipline and Healthcare Financing Amid Reimbursement Shifts
Market Street Capital is applying capital markets discipline to middle-market healthcare financing as reimbursement delays and consolidation pressure reshape how clinical labs and diagnostics operator...
NHS Rapid Brain Tumor Test Cuts Diagnosis Wait to Two Hours, Boosting Biotech Treatment Prospects
A new rapid brain tumor test developed by the University of Nottingham and adopted by NHS England reduces diagnosis time from eight weeks to about two hours, potentially accelerating access to treatme...
FDA Breakthrough Device Designation Fast-Tracked for HeartBeam's At-Home Heart Attack Assessment System
HeartBeam Inc. received FDA Breakthrough Device Designation for its at-home heart attack assessment system, potentially accelerating Medicare coverage and expanding access to timely cardiac care.
Mass General Brigham Cardiologist Emily S. Lau to Receive 2026 American Heart Association Women's Heart Health Award
Dr. Emily S. Lau of Mass General Brigham will receive the American Heart Association's 2026 Dr. Nanette K. Wenger Research Goes Red Award for her study showing a sevenfold increase in maternal cardiov...
American Heart Association Recognizes Outpatient Care Organizations in All 50 States for Cardiovascular Risk Factor Management
The American Heart Association's Outpace CVD™ program has awarded more than 2,700 outpatient care organizations across all 50 states, Washington, D.C., and Puerto Rico for improving management of high...
Wellness Index Report Reveals Shift Toward 360-Degree Wellness
A new report from Wellness Eternal shows a decisive move toward integrated care that connects mental health, hormones, and circulation, with implications for practitioners and consumers.
Wellness Index Report Highlights Shift Toward Integrated Whole-Person Care
The September 2026 Wellness Index Report reveals a growing consumer demand for integrated care that treats mental, hormonal, and circulatory health as interconnected, spotlighting three practitioners ...
SS Innovations International Expands Robotic Surgery Platform Amid Strong Revenue Growth
SS Innovations International is expanding its SSi Mantra surgical robotic platform internationally, driven by a 39.4% year-over-year revenue increase and a growing global installed base.
Healthspan Action Coalition and Italian Organizations Launch Global Collaboration to Extend Healthy Lifespan
The Healthspan Action Coalition has partnered with leading Italian health, science, academic, and civic organizations to advance research, education, and policy aimed at extending healthy human life, ...